S2 FEMORAL NAIL

{0}------------------------------------------------ Special 510(k) Premarket Notification 461 m cage Special 510(k) Summary: Line Extension to the S2 Femoral Na ## Submission Information | Name and Address of the Sponsor<br>of the 510(k) Submission: | Howmedica Osteonics Corp<br>59 Route 17<br>Allendale, NJ 07401-1677 | |--------------------------------------------------------------|---------------------------------------------------------------------| | Contact Person: | Karen Ariemma<br>Regulatory Affairs Specialist | | Date of Summary Preparation: | July 25, 2002 | | Device Identification: | | | Proprietary Name: | S2 Femoral Nail | |------------------------------------|-----------------------------------------------| | Common Name: | Intramedullary Nail, Femoral Nail | | Classification Name and Reference: | Intramedullary Fixation Rod, 21 CFR §888.3020 | This Special 510(k) submission is intended to address a line extension to the predicate S2 Femoral Nail System. The line extension involves offering larger diameters of the nail. In addition, Condyle Screws, a Condyle Nut and an additional End Cap will be added to the system. Howmedica Osteonics intends to add the new components to the current product line, thereby offering additional design options for the surgeon. There is no change in intended use for the subject components when compared to the previously cleared device. ## Intended Use The subject S2 Femoral Nail System is a fracture fixation device comprised of femoral nails and the related locking screws, compression screws, end caps, condyle screws and a condyle screw nut. The subject and predicate devices are intended to provide strong and stable internal fracture fixation with minimal soft tissue irritation. This device is utilized as an aid to healing, not as a substitute for normal intact bone and tissue. ## Statement of Technological Comparison: The material used to manufacture the line extension to the S2 Femoral Nail System is identical to that of the predicate. Mechanical testing demonstrates the comparable mechanical properties of the subject S2 Femoral Nail System to the predicate devices. {1}------------------------------------------------ Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized symbol featuring three abstract human profiles facing to the right, with flowing lines above them. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 AUG 2 2 2002 Ms. Karen Ariemma Regulatory Affairs Manager Howmedica Osteonics Corporation 59 Route 17 Allentown, New Jersey 07401-1677 Re: K022461 > Trade/Device Name: S2 Femoral Nail System Regulation Number: 888.3020 Regulation Name: Intramedullary Fixation Rod Regulatory Class: II Product Code: HSB Dated: July 25, 2002 Received: July 26, 2002 Dear Ms. Ariemma: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {2}------------------------------------------------ Page 2 – Ms. Karen Ariemma This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, Sincerely yours, Mark N. Millhussen Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ ## 510(k) Number (if known): K OQ NVVI Device Name: S2 Femoral Nail System Indications for Use The S2 Femoral Nail is indicated for long bone fracture fixation specifically femoral fracture fixation, which may include the following: - Open and closed femoral fractures . - Pseudoarthrosis and correction osteotomy . - Pathologic fractures, impending pathologic fractures, and tumor resections . - Supracondylar fractures, including those with intra-articular extension . - Ipsilateral femur fractures . - Fractures proximal to a total knee arthroplasty . - Fractures distal to a hip joint . - Nonunions and malunions . (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use OR Over-The-Counter Use (Per 21 CFR 801.109) (Optional Format 1-2-96) for Mark Millman Division Sien-Off Division of General. Restorative and Neurological Devices 516(k) Number -